A mixed methods feasibility study of nicotine-assisted smoking reduction programmes delivered by community pharmacists - The RedPharm study.

Background: Pivotal trials have established that, among people who have no immediate intention to quit smoking, nicotine replacement therapy (NRT) helps people reduce and eventually stop smoking. The prime aim of this trial was to investigate the feasibility of implementing such a programme in community pharmacies. In addition, we investigated the effectiveness of providing behavioural support compared with self-help methods and of shorter compared with standard length reduction programmes.

The effect of complementary and alternative medicine on the quality of life of cancer survivors: a systematic review and meta-analyses.

Purpose: To assess whether quality of life (QOL) improved in cancer survivors who had undertaken a complementary and alternative medicine (CAM) intervention, compared to cancer survivors who had not.

Methods: A systematic review of randomised controlled trials (RCTs) was undertaken. Electronic databases including MEDLINE, Cochrane CENTRAL, CINAHL, PSYCHINFO, EMBASE, and ClinicalTrials.

Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis.

Unlabelled: This review is an abridged version of a Cochrane Review previously published in the Cochrane Database of Systematic Reviews 2010, Issue 4, Art. No.: MR000013 DOI: 10.

A randomised trial of nicotine assisted reduction to stop in pharmacies - the RedPharm study.

Background: Public policy and clinical treatment in tobacco addiction in the UK has focused on cessation: an abrupt attempt to stop all cigarettes. However, recent evidence suggests that allowing more gradual withdrawal from tobacco or even permanent partial substitution by nicotine replacement therapy (NRT) could lead to net benefits to public health. No jurisdiction has introduced smoking reduction programmes in normal clinical care and the best methods for their implementation is uncertain.

Interventions to enhance return-to-work for cancer patients.

Background: Cancer survivors are 1.4 times more likely to be unemployed than healthy people. It is therefore important to provide cancer patients with programmes to support the return-to-work process.

Enhancing return-to-work in cancer patients, development of an intervention and design of a randomised controlled trial.

Background: Compared to healthy controls, cancer patients have a higher risk of unemployment, which has negative social and economic impacts on the patients and on society at large. Therefore, return-to-work of cancer patients needs to be improved by way of an intervention. The objective is to describe the development and content of a work-directed intervention to enhance return-to-work in cancer patients and to explain the study design used for evaluating the effectiveness of the intervention.

Strategies to improve recruitment to randomised controlled trials.

Background: Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research.

Objectives: To quantify the effects of strategies to improve recruitment of participants to randomised controlled trials.

Strategies to improve recruitment to randomised controlled trials.

Background: Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research.

Objectives: To quantify the effects of strategies to improve recruitment of participants to randomised controlled trials.

Cancer survivors and unemployment: a meta-analysis and meta-regression.

Context: Nearly half of adult cancer survivors are younger than 65 years, but the association of cancer survivorship with employment status is unknown.

Objective: To assess the association of cancer survivorship with unemployment compared with healthy controls.

Data Sources: A systematic search of studies published between 1966 and June 2008 was conducted using MEDLINE, CINAHL, EMBASE, PsycINFO, and OSH-ROM databases.

Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.

Background: Bowel cancer is common and a major cause of death. The NHS is currently rolling out a national bowel cancer screening programme that aims to cover the entire population by 2010. The programme will be based on the Faecal Occult Blood test (FOBt) that reduces mortality from colon cancer by 16%.

Comparative study of work ability between cancer survivors and their referents.

Even though cancer survivors are often able to continue working after they have been diagnosed, they may have health impairments resulting in reduced work ability. We studied the current work ability of 591 employed people with an early-stage of breast cancer, lymphoma, testicular or prostate cancer, and 757 referents. We also investigated whether the survivors perceived that cancer had impaired their work ability, and which disease-related, socio-demographic and social factors at work had an impact on their work ability.

Cancer survivors' received and needed social support from their work place and the occupational health services.

Goals Of Work: Even though a lot of studies have been conducted concerning cancer patients' social support, the importance of social support from the work life is unclear. We examined the amount of emotional and practical support that cancer survivors needed and had actually received from their coworkers, supervisors, and the occupational health personnel. We also examined whether disease-related or sociodemographic background variables were associated with needed or received support.